Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
DexCom Inc (DXCM)  
$110.57 6.07 (5.2%) as of 4:30 Mon 6/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 389,580,000
Market Cap: 43.08(B)
Last Volume: 4,690,332 Avg Vol: 1,930,532
52 Week Range: $75.49 - $140.45
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  487
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 71,005 274,979 309,595 581,627
Total Sell Value $9,585,020 $36,298,507 $40,264,880 $70,726,419
Total People Sold 8 10 14 16
Total Sell Transactions 13 27 50 85
End Date 2024-03-24 2023-12-22 2023-06-23 2022-06-23

   
Records found: 2309
  Page 37 of 93  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Moy Jeffrey SVP, Operations   •       –      –    2017-03-10 4 A $78.24 $2,034,318 I/I 26,001 76,557     -
   Moy Jeffrey SVP, Operations   •       –      –    2017-03-10 4 D $78.24 $2,034,318 D/D (26,001) 57,486     -
   Balo Andrew K EVP, Clinical and Regulatory   •       –      –    2017-03-10 4 D $77.55 $1,041,505 D/D (13,430) 116,033     -
   Balo Andrew K EVP, Clinical and Regulatory   •       –      –    2017-03-10 4 AS $77.71 $248,672 D/D (3,200) 129,463     -
   Doubleday Richard EVP, Chief Commercial Officer   •       –      –    2017-03-10 4 D $77.55 $1,041,427 D/D (13,429) 97,815     -
   Pacelli Steven Robert EVP, Strategy & Corp. Dev.   •       –      –    2017-03-10 4 D $77.55 $1,167,757 D/D (15,058) 122,861     -
   Lister John General Manager, EMEA   •       –      –    2017-03-10 4 D $77.55 $752,086 D/D (9,698) 84,034     -
   Sayer Kevin R President & CEO   •       •      –    2017-03-10 4 D $77.55 $614,744 D/D (7,927) 343,680     -
   Gregg Terrance H Executive Chairman   •       •      –    2017-03-10 4 D $77.55 $1,254,226 D/D (16,173) 454,559     -
   Murphy Patrick Michael VP, Legal Aff & Chf Compl Ofcr   •       –      –    2017-03-10 4 D $77.55 $468,095 D/D (6,036) 34,453     -
   Ace Heather S SVP Human ResourcesOfficer   •       –      –    2017-03-09 3 IO $0.00 $0 D/D 0 49,383     -
   Collins Richard Alexander Director   –       •      –    2017-03-09 3 IO $0.00 $0 D/D 0 500     -
   Leach Jacob Steven SVP, Research & Development   •       –      –    2017-03-09 4 S $77.24 $801,072 D/D (10,341) 95,592     -
   Lister John General Manager, EMEA   •       –      –    2017-03-09 4 AS $77.67 $233,002 D/D (3,000) 93,732     -
   Lister John General Manager, EMEA   •       –      –    2017-03-09 4 OE $8.85 $26,550 D/D 3,000 96,732     -
   Doubleday Richard EVP, Chief Commercial Officer   •       –      –    2017-03-08 4 A $0.00 $28 D/D 27,510 111,244     -
   Pacelli Steven Robert EVP, Strategy & Corp. Dev.   •       –      –    2017-03-08 4 A $0.00 $28 D/D 27,510 137,919     -
   Moy Jeffrey SVP, Operations   •       –      –    2017-03-08 4 A $0.00 $22 D/D 21,883 83,487     -
   Lister John General Manager, EMEA   •       –      –    2017-03-08 4 A $0.00 $23 D/D 23,134 93,732     -
   Sayer Kevin R President & CEO   •       •      –    2017-03-08 4 D $77.55 $2,253,931 D/D (29,064) 351,607     -
   Sayer Kevin R President & CEO   •       •      –    2017-03-08 4 A $0.00 $81 D/D 81,280 380,671     -
   Gregg Terrance H Executive Chairman   •       •      –    2017-03-08 4 A $0.00 $31 D/D 30,887 470,732     -
   Abbey Donald EVP Quality   •       –      –    2017-03-08 4 A $0.00 $28 D/D 27,510 82,510     -
   Murphy Patrick Michael VP, Legal Aff & Chf Compl Ofcr   •       –      –    2017-03-08 4 A $0.00 $11 D/D 11,361 40,489     -
   Balo Andrew K EVP, Clinical and Regulatory   •       –      –    2017-03-08 4 A $0.00 $29 D/D 28,761 132,663     -
  2309 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 37 of 93
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us